Carcinoid syndrome epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
(→Gender) |
|||
| Line 17: | Line 17: | ||
===Gender=== | ===Gender=== | ||
*Females are more commonly affected with carcinoid syndrome | *Females are more commonly affected with carcinoid syndrome than males. | ||
*Males are more commonly affected with thymic carcinoid tumor than females The male to female ratio is approximately 3 to 1.<ref> Thymic carcinoid tumour. Radiopaedia. http://radiopaedia.org/articles/thymic-carcinoid-tumour Accessed on September 24, 2015</ref> | *Males are more commonly affected with thymic carcinoid tumor than females The male to female ratio is approximately 3 to 1.<ref> Thymic carcinoid tumour. Radiopaedia. http://radiopaedia.org/articles/thymic-carcinoid-tumour Accessed on September 24, 2015</ref> | ||
Revision as of 16:04, 29 September 2015
|
Carcinoid syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Carcinoid syndrome epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Carcinoid syndrome epidemiology and demographics |
|
Carcinoid syndrome epidemiology and demographics in the news |
|
Risk calculators and risk factors for Carcinoid syndrome epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
The prevalence of carcinoid syndrome is approximately 1.5 per 100,000 individuals worldwide. The incidence of carcinoid syndrome is approximately 15 per 100,000 individuals worldwide. The median age at diagnosis is 61.4 years.
Epidemiology and Demographics
Incidence
- The incidence of carcinoid syndrome is estimated to be 2 cases per 100,000 individuals worldwide.[1]
- The median age at diagnosis is 60.9 years.[2]
- Carcinoid tumors represent about 0.5% of all newly diagnosed malignancies.
- Carcinoid tumors account for 75% of all gastrointestinal endocrine tumors.
- Ovarian carcinoid tumors account for 0.3% of all ovarian tumors and 0.5% of carcinoid tumors.[3]
Age
- Ovarian carcinoid tumors are commonly seen in perimenopausal and postmenopausal women.
Gender
- Females are more commonly affected with carcinoid syndrome than males.
- Males are more commonly affected with thymic carcinoid tumor than females The male to female ratio is approximately 3 to 1.[4]
References
- ↑ Epidemiology of carcinoid tumor. National cancer institute. http://www.cancer.gov/types/gi-carcinoid-tumors/hp/gi-carcinoid-treatment-pdq
- ↑ Maggard MA, O'Connell JB, Ko CY (2004). "Updated population-based review of carcinoid tumors". Ann Surg. 240 (1): 117–22. PMC 1356383. PMID 15213627.
- ↑ Ovarian carcinoid tumors.Radiopaedia (date). http://radiopaedia.org/articles/ovarian-carcinoid-tumours
- ↑ Thymic carcinoid tumour. Radiopaedia. http://radiopaedia.org/articles/thymic-carcinoid-tumour Accessed on September 24, 2015